Literature DB >> 10037630

Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study.

L A Rodríguez1, A Ruigómez.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10037630      PMCID： PMC27756          DOI： 10.1136/bmj.318.7183.565

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

1.  Gastric acid, acid-suppressing drugs, and bacterial gastroenteritis: how much of a risk?

Authors:  L A Garcia Rodríguez; A Ruigómez
Journal:  Epidemiology       Date:  1997-09       Impact factor: 4.822

2.  Use of the UK General Practice Research Database for pharmacoepidemiology.

Authors:  L A García Rodríguez; S Pérez Gutthann
Journal:  Br J Clin Pharmacol       Date:  1998-05       Impact factor: 4.335

3.  Prevalence of gastrointestinal symptoms after bacterial gastroenteritis. Study did not include a control group.

Authors:  R Barber; A Blakey
Journal:  BMJ       Date:  1997-06-28

4.  Irritable bowel syndrome--post salmonella infection.

Authors:  M W McKendrick; N W Read
Journal:  J Infect       Date:  1994-07       Impact factor: 6.072

5.  Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients.

Authors:  K R Neal; J Hebden; R Spiller
Journal:  BMJ       Date:  1997-03-15
  5 in total
  84 in total

1.  British Society of Gastroenterology guidelines for the management of the irritable bowel syndrome.

Authors:  J Jones; J Boorman; P Cann; A Forbes; J Gomborone; K Heaton; P Hungin; D Kumar; G Libby; R Spiller; N Read; D Silk; P Whorwell
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

2.  East meets West: infection, nerves, and mast cells in the irritable bowel syndrome.

Authors:  S M Collins; G Barbara
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

Review 3.  Putative therapeutic targets in the treatment of visceral hyperalgesia.

Authors:  S Collins
Journal:  Gut       Date:  2004-03       Impact factor: 23.059

Review 4.  Clinical metabolomics paves the way towards future healthcare strategies.

Authors:  Sebastiano Collino; François-Pierre J Martin; Serge Rezzi
Journal:  Br J Clin Pharmacol       Date:  2013-03       Impact factor: 4.335

5.  Effect of probiotics on gastrointestinal function: evidence from animal models.

Authors:  Elena F Verdú; Premysl Bercik; Stephen M Collins
Journal:  Therap Adv Gastroenterol       Date:  2009-07       Impact factor: 4.409

Review 6.  Post-infectious IBS, tropical sprue and small intestinal bacterial overgrowth: the missing link.

Authors:  Uday C Ghoshal; Kok-Ann Gwee
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2017-05-17       Impact factor: 46.802

Review 7.  Global burden of irritable bowel syndrome: trends, predictions and risk factors.

Authors:  Christopher J Black; Alexander C Ford
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-04-15       Impact factor: 46.802

8.  Concurrent infection with Schistosoma mansoni attenuates inflammation induced changes in colonic morphology, cytokine levels, and smooth muscle contractility of trinitrobenzene sulphonic acid induced colitis in rats.

Authors:  T G Moreels; R J Nieuwendijk; J G De Man; B Y De Winter; A G Herman; E A Van Marck; P A Pelckmans
Journal:  Gut       Date:  2004-01       Impact factor: 23.059

Review 9.  Post-infectious irritable bowel syndrome.

Authors:  Andrew W Dupont
Journal:  Curr Gastroenterol Rep       Date:  2007-10

10.  Twenty-four-hour manometric study of colonic propulsive activity in patients with diarrhea due to inflammatory (ulcerative colitis) and non-inflammatory (irritable bowel syndrome) conditions.

Authors:  Gabrio Bassotti; Giuseppe de Roberto; Fabio Chistolini; Francis Sietchiping-Nzepa; Olivia Morelli; Antonio Morelli
Journal:  Int J Colorectal Dis       Date:  2004-04-09       Impact factor: 2.571
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.